Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical study

Karolinska TORCH Infection Autism Study

Analysis based on 8 articles · First reported Sep 21, 2026 · Last updated Sep 24, 2026

Sentiment
5
Attention
1
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The findings are supportive for vaccine makers and diagnostic/screening providers, as they reinforce the public-health case for mass vaccination and expanded newborn screening for TORCH infections. Direct market impact is limited because the study concerns a rare condition with no listed commercial sponsor, so any effect is likely confined to sentiment around preventive healthcare and diagnostics.

healthcare pharmaceuticals vaccines

A large Swedish register study from Karolinska Institutet, published in JAMA Pediatrics, found that congenital TORCH infections - a group of pathogens including cytomegalovirus, rubella, toxoplasma, syphilis and herpesvirus that can cross the placenta from a pregnant woman to the fetus - are linked to substantially higher risks of autism and intellectual disability later in life. The study followed 3.7 million people born in Sweden between 1987 and 2021, of whom 975 had been diagnosed with a congenital TORCH infection, for up to three decades. Children with such an infection were about three times more likely to be diagnosed with autism, more than seven times more likely to be diagnosed with an intellectual disability, and up to 30 times more likely to have severe to profound intellectual disability. Because the infections are rare, they account for only a small share of cases at the population level - roughly 1.2 percent of severe intellectual disability cases and 0.034 percent of autism cases in Sweden - though about one in five affected children may later develop autism. Sibling comparisons produced similar results, and even children without a diagnosis had lower average school grades. The authors, including Reneé Gardner and lead author Hugo Sjöqvist, emphasize prevention, vaccination programs and better screening for asymptomatic cases. The research was funded by the Sweden — Swedish Research Council; co-author David Mataix-Cols disclosed author fees from UpToDate and a partnership in Scandinavian E-Health AB.

5 Scandinavian E-Health AB held partnership
cnt
The study is based on Sweden's national registers covering its population, and its vaccination and screening policies are the main public-health context for the findings.
Importance 55.0 Sentiment 5.0
govactor
The council funded the research, supporting the study without direct commercial exposure.
Importance 30.0 Sentiment 0.0
priv
Co-author David Mataix-Cols is a partner in this e-health company, a disclosed but unrelated interest with no direct link to the study.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.